Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Pharmaceuticals Major
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| JNJ | Johnson & Johnson | 0.74% | 178.16 | 0.7% | $1431.81m | |
| PFE | Pfizer Inc. | 1.14% | 50.49 | 0.9% | $1327.24m | |
| ABBV | AbbVie, Inc. | 1.44% | 155.71 | 1.9% | $1240.79m | |
| BMY | Bristol-Myers Squibb Co. | 1.49% | 76.93 | 1.0% | $1167.46m | |
| MRK | Merck & Co., Inc. | 2.14% | 92.34 | 0.7% | $1088.82m | |
| LLY | Eli Lilly & Co. | 2.78% | 299.73 | 1.1% | $823.15m | |
| AZN | AstraZeneca Plc | 2.14% | 64.49 | 1.0% | $478.91m | |
| VERU | Veru, Inc. | 3.85% | 13.50 | 0.0% | $403.25m | |
| BHVN | Biohaven Pharmaceutical Holding Co. Ltd. | -0.38% | 140.46 | 0.0% | $394.02m | |
| GSK | GlaxoSmithKline Plc | 2.42% | 44.37 | 0.2% | $223.17m | |
| NVS | Novartis AG | 2.33% | 87.82 | 0.2% | $219.85m | |
| HZNP | Horizon Therapeutics Plc | 0.43% | 90.82 | 5.4% | $198.56m | |
| NVO | Novo Nordisk A/S | -2.65% | 103.23 | 0.1% | $166.43m | |
| SGEN | Seagen Inc. | 5.10% | 142.54 | 5.7% | $163.52m | |
| CTLT | Catalent, Inc. | -0.56% | 97.63 | 2.0% | $158.65m |
Company Profile
Xenetic Biosciences, Inc. is a biopharmaceutical company engaged in the advancement of cell-based therapeutics to target the B-cell receptor on the surface of an individual patient’s malignant tumor cells. Its product pipeline includes XCart Platform and Polyxen. The company was founded on August 9, 2011 and is headquartered in Framingham, MA.